Cargando…
Eight‐year follow‐up outcome of subthalamic deep brain stimulation for Parkinson’s disease: Maintenance of therapeutic efficacy with a relatively low levodopa dosage and stimulation intensity
AIMS: This follow‐up study aimed to examine the 8‐year efficacy and safety of subthalamic nucleus (STN) deep brain stimulation (DBS) for patients with Parkinson's disease (PD) in southern China. METHODS: The follow‐up data of 10 patients with PD undergoing STN‐DBS were analyzed. Motor symptoms...
Autores principales: | Jiang, Lulu, Chen, Wanru, Guo, Qiyu, Yang, Chao, Gu, Jing, Xian, Wenbiao, Liu, Yanmei, Zheng, Yifan, Ye, Jing, Xu, Shaohua, Hu, Yu, Wu, Lei, Chen, Jie, Qian, Hao, Fu, Xiaoli, Liu, Jinlong, Chen, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504521/ https://www.ncbi.nlm.nih.gov/pubmed/34350691 http://dx.doi.org/10.1111/cns.13713 |
Ejemplares similares
-
The efficacy and safety of asleep and awake subthalamic deep brain stimulation for Parkinson’s disease patients: A 1-year follow-up
por: Chen, Wanru, et al.
Publicado: (2023) -
Early versus Late Application of Subthalamic deep brain Stimulation to Parkinson’s disease patients with motor complications (ELASS): protocol of a multicentre, prospective and observational study
por: Jiang, Lulu, et al.
Publicado: (2017) -
Levodopa Versus Dopamine Agonist after Subthalamic Stimulation in Parkinson's Disease
por: Picillo, Marina, et al.
Publicado: (2020) -
The Role of Levodopa Challenge in Predicting the Outcome of Subthalamic Deep Brain Stimulation
por: Wolke, Robin, et al.
Publicado: (2023) -
Effect of Subthalamic Deep Brain Stimulation on Levodopa-Induced Dyskinesia in Parkinson's Disease
por: Kim, Ji Hee, et al.
Publicado: (2015)